JA-MAE CHAMBERS: Open Payments
NPI 1053500819 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 18 payments from 10 companies in 2025. Trend: 2023 $389 · 2024 $909 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 2 | $57 |
| Shionogi Inc | 2 | $57 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| Gilead Sciences, Inc. | 2 | $40 |
| Insmed, Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| Calliditas Therapeutics US Inc. | 1 | $34 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
Products named: JYNARQUE, Fetroja, VOWST, EMBLAVEO, Arikayce, ZERBAXA, TARPEYO, XERAVA.
Industry payments across IN — which companies pay providers there.
